Making the Invisible Visible: Unlocking the Potential of Imaging Mass Spectrometry in Ovarian Carcinoma and Beyond

Wszystkich zainteresowanych serdecznie zapraszamy do wzięcia udziału w seminarium:

Making the Invisible Visible: Unlocking the Potential of Imaging Mass Spectrometry in Ovarian Carcinoma and Beyond – Bruker Webinar.

Udział w wydarzeniu jest bezpłatny, jednak wymagana jest wcześniejsza rejestracja.

Więcej informacji oraz link do rejestracji znajdują się poniżej.

https://www.bruker.com/en/news-and-events/webinars/2026/making-the-invisible-visible-unlocking-the-potential-of-imaging-mass-spectrometry-in-ovarian-carcinoma-and-beyond.html

Overview

Discover new perspectives on the complexity of high‑grade serous ovarian cancer in our upcoming webinar, where cutting‑edge spatial multiomics meets real impact. Learn how MALDI Imaging, combined with LMD‑based proteomics, spatial transcriptomics, and MALDI HiPLEX-IHC, is revealing previously unseen cellular subpopulations linked to treatment response and patient survival. This integrated strategy uncovers critical interactions between tumor and microenvironment that may drive chemoresistance and could pave the way for improved patient stratification. Join us to explore these groundbreaking results and see how spatial biology is transforming the future of cancer research.